Future Journal of Pharmaceutical Sciences

Table 4 Hip T-scores at baseline and after one year of treatment

From: Optimization of osteoporosis and osteopenia management among renal transplant recipients

	Baseline	After 1 year	Net change	P value
Hip Osteoporosis
Denosumab	−3.45 (± 0.4)	−3.1 (± 0.5)	0.35	0.34^a
Ibandronate	−3.1 (± 0.6)	−3.12 (± 0.52)	−0.02	0.91^a
Hip Osteopenia
Denosumab	−1.5 (± 0.2)	−1.3 (± 0.42)	0.2	0.12^a
Ibandronate	−1.4 (± 0.23)	−1.45 (± 0.46)	−0.05	0.81^a

The Student T-test was used for normally distributed variables; significance was found at P ≤ 0.05
^aNonsignificant difference between the two groups

Back to article page